Virtus LifeSci Valuation Overview

BBC -- USA Etf  

USD 33.78  0.30  0.88%

Virtus LifeSci Biotech has current Real Value of $31.74 per share. The regular price of the etf is $33.78. At this time the etf appears to be over valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 347, Net Asset of 78.38M and Price to Earning of 39.87times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
 Time Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Clinical Trls ETF is rated below average in price to book as compared to similar ETFs. It is second largest ETF in price to earning as compared to similar ETFs reporting about  22.78  of Price to Earning per Price to Book.

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries
Over Valued
July 22, 2018
Market Value
Real Value
Target Odds
Virtus LifeSci is not too volatile asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.